Details of the Drug
General Information of Drug (ID: DMRHOFB)
| Drug Name |
Ferritarg P
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Ferritarg; Ferrotarg P; Hodgkins disease therapy (polyclonal antibody), MAT Biopharma; Y90 anti-ferritin polyclonal antibody (Hodgkins disease), MAT Biopharma; Yttrium-90 anti-ferritin polyclonal antibody (Hodgkins disease), MAT Biopharma; Yttrium-90 anti-ferritin polyclonal antibody (refractory Hodgkin! s disease), MAT Biopharma; 90Y-labelled anti-ferritin polyclonal antibody (Hodgkins disease), MAT Biopharma; 90Y-labelled polyclonal IgG (Hodgkins disease), MAT Biopharma; 90Y-labelled polyclonal immunoglobulin G (Hogkinsdisease), MAT biopharma
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Antibody
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
References

